|
May 12, 2008, 23:41 | 0 (0 Votes) | 0 Comments
AstraZeneca's Toprol Raises Risk of Death, Stroke, Study Says
... beta-blocker regimen has benefit without substantial harm,'' authors led by researcher PJ Devereaux from McMaster University in Hamilton, Ontario wrote. ...
Please log in to rate this.
|
Comments (0)
No one has posted any comments yet. Perhaps you'd like to be the first?
Please log in to add comment.
